Document Detail

Efficacy and safety of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C.
MedLine Citation:
PMID:  18186564     Owner:  NLM     Status:  MEDLINE    
AIM: To evaluate the efficacy and safety of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C.
METHODS: Thirty-six hemodialysis patients with chronic hepatitis C were enrolled in a controlled and prospective study. All patients were treatment naive, positive tested for anti-HCV antibodies, and positive tested for serum HCV-RNA. Twenty-two patients received 135 microg peglyated-interferon alpha-2a weekly for 48 wk (group A). The remaining patients were left untreated, eleven refused therapy, and three were not candidates for kidney transplantation and were allocated to the control group (group B). At the end of the treatment biochemical and virological response was evaluated, and 24 wk after completion of therapy sustained virological response (SVR) was assessed. Side effects were monitored.
RESULTS: Of 22 hemodialysis patients, 12 were male and 10 female, with a mean age of 35.2 +/- 12.1 years. Virological end-of-treatment response was observed in 14 patients (82.4%) in group A and in one patient (7.1%) in group B (P = 0.001). Sustained virological response was observed in 11 patients (64.7%) in group A and in one patient in group B (7.1%). Biochemical response parameters normalized in 10/14 patients (71.4%) at the end of the treatment. ALT levels in group B were initially high in six patients and normalized in one of them (25%) at the end of the 48 wk. In five patients (22.7%) therapy had to be stopped at mo 4 due to complications of weakness, anemia, and bleeding.
CONCLUSION: SVR could be achieved in 64.7% of patients on hemodialysis with chronic hepatitis C by a treatment with peglyated-interferon alpha-2a. Group A had a significantly better efficacy compared to the control group B, but the side effects need to be concerned.
Celal Ayaz; Mustafa Kemal Celen; Ugur Nedim Yuce; Mehmet Faruk Geyik
Related Documents :
8560404 - High lipoprotein (a) levels in chronic hemodialysis patients are closely related to the...
16749554 - Can early hemodialysis affect the outcome of the ingestion of glyphosate herbicide?
2918944 - Aluminum removal with hemodialysis, hemofiltration and charcoal hemoperfusion in uremic...
2020344 - Utility of venography in shunt surgery on hemodialyzed patients.
19456234 - Heterozygosity for the s180l variant of mal/tirap, a gene expressing an adaptor protein...
492754 - Experiences with high tetraplegics.
Publication Detail:
Type:  Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  World journal of gastroenterology : WJG     Volume:  14     ISSN:  1007-9327     ISO Abbreviation:  World J. Gastroenterol.     Publication Date:  2008 Jan 
Date Detail:
Created Date:  2008-01-11     Completed Date:  2008-04-30     Revised Date:  2013-06-06    
Medline Journal Info:
Nlm Unique ID:  100883448     Medline TA:  World J Gastroenterol     Country:  China    
Other Details:
Languages:  eng     Pagination:  255-9     Citation Subset:  IM    
Department of Clinical Microbiology and Infectious Diseases, Dicle University Hospital, Diyarbakir, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antiviral Agents / administration & dosage*,  adverse effects
Hepatitis C, Chronic / complications*,  drug therapy*
Interferon-alpha / administration & dosage*,  adverse effects
Kidney Failure, Chronic / complications*,  therapy
Middle Aged
Polyethylene Glycols / administration & dosage*,  adverse effects
Recombinant Proteins
Renal Dialysis
Treatment Outcome
Reg. No./Substance:
0/Antiviral Agents; 0/Interferon-alpha; 0/Polyethylene Glycols; 0/Recombinant Proteins; 0/peginterferon alfa-2a; 76543-88-9/interferon alfa-2a

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prevalence and dietetic management of mild gastrointestinal disorders in milk-fed infants.
Next Document:  Role of echo Doppler ultrasonography in the evaluation of postprandial hyperemia in cirrhotic patien...